Organization: VIMAC Milestone Medica Fund

Mimetogen Pharmaceuticals receives series A financing

McGill Univ spinoff Mimetogen Pharmaceuticals Inc has received series A financing from a venture capital consortium led by Boston-based VIMAC Milestone Medica Fund. Also participating is original investor MSBi Capital, a seed and early-stage fund created to commercialize technologies from McGill, Univ of Sherbrooke and Bishop’s Univ. Mimetogen is currently developing therapeutic approaches for small…